enVVeno Medical
NVNO
enVVeno Medical (NVNO) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$11.55
- EPS estimate
- −$9.80
- EPS surprise
- −17.86%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Jul 31, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Jul 31, 2025 | −$9.80 | −$11.55 | −17.86% | $0.00 | SEC |
| Q1 2025 | Apr 30, 2025 | −$11.90 | −$7.70 | +35.29% | $0.00 | SEC |
| Q4 2024 | Feb 28, 2025 | −$12.25 | −$10.88 | +11.17% | $0.00 | SEC |
| Q3 2024 | Oct 31, 2024 | −$11.55 | −$12.25 | −6.06% | $0.00 | SEC |
| Q2 2024 | Jul 31, 2024 | −$12.60 | −$10.85 | +13.89% | $0.00 | SEC |
| Q1 2024 | May 8, 2024 | −$14.00 | −$10.85 | +22.50% | $0.00 | SEC |
| Q3 2023 | Oct 26, 2023 | −$16.80 | −$15.75 | +6.25% | $0.00 | SEC |
| Q2 2023 | Jul 31, 2023 | −$17.15 | −$20.30 | −18.37% | $0.00 | SEC |
| Q3 2022 | Oct 27, 2022 | −$18.20 | −$18.90 | −3.85% | $0.00 | — |
| Q2 2022 | Aug 3, 2022 | −$11.55 | −$22.05 | −90.91% | $0.00 | — |
| Q2 2021 | Aug 11, 2021 | −$11.90 | −$9.80 | +17.65% | $0.00 | — |
| Q3 2020 | Nov 17, 2020 | −$43.75 | −$43.75 | +0.00% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did enVVeno Medical (NVNO) last report earnings?
enVVeno Medical last reported on Jul 31, 2025, covering fiscal Q2 2025.
Did NVNO beat earnings estimates?
No. enVVeno Medical reported EPS of −$11.55 for Q2 2025 against a −$9.80 estimate — a 17.86% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.